Vanda Pharmaceuticals Inc. Stock Analysis & AI Score
Vanda Pharmaceuticals Inc. (VNDA) has an ST Score of 36.1 (C), driven by its Forecast (A) and held back by its Financial Strength (D-). Analysts rate it Buy with a $15.50 price target (+211.2% upside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Vanda Pharmaceuticals Inc. (VNDA) has an ST Score of 36.1 (C), driven by its Forecast (A) and held back by its Financial Strength (D-). Analysts rate it Buy with a $15.50 price target (+211.2% upside).
- Strongest
- ForecastA
- Weakest
- Financial StrengthD-
All factor grades
- ForecastA
- MomentumC+
- ValuationC-
- GrowthC-
- ProfitabilityD
- Financial StrengthD-
- Piotroski3/9
Contact
VNDA stock: frequently asked questions
What is VNDA's ST Score?
Vanda Pharmaceuticals Inc. (VNDA) has an ST Score of 36.1 (C), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is VNDA a buy, hold, or sell?
Analysts rate VNDA a Buy, with a price target of $15.50 (+211.2% vs the current price). Our ST Score grades it C (36.1/100). The ST Score is a data-driven signal, not a recommendation.
What are VNDA's factor grades?
Valuation C-, Profitability D, Financial Strength D-, Momentum C+, Growth C-, Forecast A.
What is VNDA's valuation grade?
Vanda Pharmaceuticals Inc. (VNDA) earns a valuation grade of C-, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is VNDA's growth grade?
Vanda Pharmaceuticals Inc. (VNDA) earns a growth grade of C-, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is VNDA's profitability grade?
Vanda Pharmaceuticals Inc. (VNDA) earns a profitability grade of D, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is VNDA's financial strength grade?
Vanda Pharmaceuticals Inc. (VNDA) earns a financial strength grade of D-, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for VNDA?
The average analyst price target for Vanda Pharmaceuticals Inc. (VNDA) is $15.50 from 19 analysts, which is +211.2% versus the recent price of $4.98.
What is VNDA's Piotroski score?
Vanda Pharmaceuticals Inc. (VNDA) has a Piotroski F-Score of 3 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.